MGMT-Unmethylated Glioblastoma — Trials

MGMT-Unmethylated Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

19 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 10
Recruiting: 7
Ph III recruiting: 1
Growth YoY: —
Industry share: 0%
Top sponsor: Northwestern University
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (2)

clinicaltrialsPublishedShowing 1–19 of 19 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07452458	Temporally-Modulated Pulsed Radiation Therapy Versus Standard Radiation Therapy for the Treatment of Newly Diagnosed, IDH Wildtype, MGMT-Unmethylated Glioblastoma	recruiting	Phase 3	398	NRG OncologyOTHER	1	Sep 10, 2026	clinicaltrials
NCT05236036	Mycophenolate Mofetil in Combination With Standard of Care for the Treatment of Glioblastoma	active not recruiting	Phase 1	86	Northwestern UniversityOTHER	1	Aug 26, 2026	clinicaltrials